Oncology - European Medical Journal

Continue

Oncology

Filter
7 Mins
31 Aug 2017

Editor’s Pick: Renal Involvement in Multiple Myeloma

Multiple myeloma (MM) is a plasma cell disorder that represents almost 10% of haematologic malignancies.
8 Mins
31 Aug 2017

A Theoretical View of Ovarian Cancer Relapse

Ovarian cancer (OC) is a disease that almost invariably relapses even after optimal primary cytoreductive surgery and standard first-line platinum-based…
3 Mins
25 Aug 2017

Mesothelioma: A Dormant Threat

The industrialised world is truly a marvel; through years of innovation and invention, society has been rewarded with extreme technological advances.
3 Mins
9 Aug 2017

Spasmodic Dysphonia: What About It?

Spasmodic dysphonia (SD): what about it? That is the million-dollar question.
13 Dec 2016

Recent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the Meeting of the European Society for Medical Oncology (ESMO) Congress 2016

The European Society for Medical Oncology (ESMO) Congress was held in Copenhagen, Denmark from 7th–11th October 2016. The use of the promiscuous…
9 Mins
22 Nov 2016

State-of-the-Art Integration of Multiple Kinase Inhibitors in the Treatment of Gastrointestinal Cancers

This symposium provided an overview of the efficacy and safety of multikinase inhibitors in colorectal cancer, including treatment sequencing, followed…
10 Mins
22 Nov 2016

Optimising Salvage Therapy in Aggressive B Cell Non-Hodgkin Lymphoma

Prof D’Amore opened the symposium by highlighting that management of patients with relapsed or refractory aggressive B cell non-Hodgkin lymphoma…
2 Mins
22 Nov 2016

Cabozantinib as First-Line Therapy for Patients with Metastatic Renal Cell Carcinoma with Poor or Intermediate-Risk Characteristics

The oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI) sunitinib is a standard first-line therapy for patients with…